Purity | Size | Price | VIP Price | USA Stock *0-1 Day | Global Stock *5-7 Days | Quantity | |||||
{[ item.p_purity ]} | {[ item.pr_size ]} |
{[ getRatePrice(item.pr_usd, 1,1) ]} {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate) ]} |
{[ getRatePrice(item.pr_usd, 1,1) ]} | Inquiry {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate) ]} {[ getRatePrice(item.pr_usd,1,item.mem_rate) ]} | {[ item.pr_usastock ]} | Inquiry - | {[ item.pr_chinastock ]} | Inquiry - |
* Storage: {[proInfo.prStorage]}
CAS No. : | 343246-61-7 | MDL No. : | MFCD18071021 |
Formula : | C7H11N3O | Boiling Point : | - |
Linear Structure Formula : | - | InChI Key : | HVPGJKMIHQOPDG-LURJTMIESA-N |
M.W : | 153.18 | Pubchem ID : | 28063787 |
Synonyms : |
|
Num. heavy atoms : | 11 |
Num. arom. heavy atoms : | 5 |
Fraction Csp3 : | 0.71 |
Num. rotatable bonds : | 1 |
Num. H-bond acceptors : | 4.0 |
Num. H-bond donors : | 1.0 |
Molar Refractivity : | 43.25 |
TPSA : | 50.95 Ų |
GI absorption : | High |
BBB permeant : | No |
P-gp substrate : | No |
CYP1A2 inhibitor : | No |
CYP2C19 inhibitor : | No |
CYP2C9 inhibitor : | No |
CYP2D6 inhibitor : | No |
CYP3A4 inhibitor : | No |
Log Kp (skin permeation) : | -6.9 cm/s |
Log Po/w (iLOGP) : | 2.12 |
Log Po/w (XLOGP3) : | 0.47 |
Log Po/w (WLOGP) : | 0.1 |
Log Po/w (MLOGP) : | 0.16 |
Log Po/w (SILICOS-IT) : | 1.41 |
Consensus Log Po/w : | 0.85 |
Lipinski : | 0.0 |
Ghose : | None |
Veber : | 0.0 |
Egan : | 0.0 |
Muegge : | 1.0 |
Bioavailability Score : | 0.55 |
Log S (ESOL) : | -1.36 |
Solubility : | 6.75 mg/ml ; 0.044 mol/l |
Class : | Very soluble |
Log S (Ali) : | -1.11 |
Solubility : | 11.9 mg/ml ; 0.0778 mol/l |
Class : | Very soluble |
Log S (SILICOS-IT) : | -2.17 |
Solubility : | 1.04 mg/ml ; 0.00681 mol/l |
Class : | Soluble |
PAINS : | 0.0 alert |
Brenk : | 0.0 alert |
Leadlikeness : | 1.0 |
Synthetic accessibility : | 3.11 |
Signal Word: | Warning | Class: | N/A |
Precautionary Statements: | P280-P305+P351+P338-P310 | UN#: | N/A |
Hazard Statements: | H302-H315-H319-H332-H335 | Packing Group: | N/A |
GHS Pictogram: |
* All experimental methods are cited from the reference, please refer to the original source for details. We do not guarantee the accuracy of the content in the reference.
[ 1121057-52-0 ]
3-Methyl-5-(pyrrolidin-3-yl)-1,2,4-oxadiazole hydrochloride
Similarity: 0.73
[ 1121057-52-0 ]
3-Methyl-5-(pyrrolidin-3-yl)-1,2,4-oxadiazole hydrochloride
Similarity: 0.73
[ 1184986-84-2 ]
(5-Methyl-1,2,4-oxadiazol-3-yl)methanamine hydrochloride
Similarity: 0.58
[ 1192-80-9 ]
3-(Chloromethyl)-5-methyl-1,2,4-oxadiazole
Similarity: 0.58
[ 1245645-77-5 ]
Ethyl 5-ethyl-1,2,4-oxadiazole-3-carboxylate
Similarity: 0.53
[ 158154-63-3 ]
Ethyl 5-(tert-butyl)-1,2,4-oxadiazole-3-carboxylate
Similarity: 0.51